Patient | Sex | Age (years) | Disease | Anti-CCP/ RF-IgM/RF-IgA | Disease Activity Score | IHC |
---|---|---|---|---|---|---|
1 | F | 73 | RA | −/−/− | 2.8 | Diffuse |
2 | M | 78 | RA | −/−/− | 3.6 | Diffuse |
3 | F | 32 | RA | +/−/− | 3.4 | Diffuse |
4 | M | 78 | RA | −/−/− | 5.5 | Diffuse |
5 | F | 76 | RA | −/−/− | 7.4 | Diffuse |
6 | M | 43 | RA | −/−/− | 4.2 | Diffuse |
7 | F | 69 | RA | −/−/− | 3.8 | Diffuse |
8 | F | 67 | RA | +/+/− | 5.6 | Diffuse |
9 | F | 40 | RA | +/−/− | 4.1 | Diffuse |
10 | F | 73 | RA | +/−/− | 2.6 | Diffuse |
11 | M | 63 | RA | +/+/+ | 2.9 | Diffuse |
12 | F | 47 | RA | +/+/+ | 3.9 | Diffuse |
13 | F | 19 | RA | +/−/− | 2.8 | Diffuse |
14 | F | 59 | RA | +/−/− | 4.5 | Aggregate |
15 | F | 58 | RA | −/−/− | 6.1 | Aggregate |
16 | M | 38 | RA | −/+/− | 1.2 | Aggregate |
17 | F | 77 | RA | +/−/− | 5.6 | Aggregate |
18 | F | 71 | RA | +/−/− | 4.9 | Aggregate |
19 | F | 67 | RA | +/−/− | 2.3 | Aggregate |
20 | M | 35 | RA | −/−/− | 3.1 | Aggregate |
21 | M | 68 | RA | +/−/− | 5.6 | Aggregate |
22 | F | 51 | RA | −/−/− | 2.9 | Aggregate |
23 | F | 24 | RA | −/−/− | 4.2 | Aggregate |
24 | M | 22 | RA | −/−/− | 2.8 | Aggregate |
25 | M | 25 | RA | −/−/− | 1.7 | Aggregate |
26 | F | 77 | RA | +/+/− | 3.5 | Aggregate |
27 | F | 47 | RA | −/−/− | 6.4 | Aggregate |
28 | F | 70 | Mono-arthritis | −/−/− | — | Diffuse |
29 | M | 51 | Mono-arthritis | −/−/− | — | Diffuse |
30 | F | 57 | Mono-arthritis | −/−/− | — | Diffuse |
31 | F | 71 | Mono-arthritis | −/+/− | — | Diffuse |
32 | F | 27 | Mono-arthritis | −/−/− | — | Diffuse |
33 | F | 56 | Mono-arthritis | −/−/− | — | Diffuse |
34 | M | 54 | Mono-arthritis | −/−/− | — | Aggregate |
35 | F | 26 | Mono-arthritis | −/−/− | — | Aggregate |
36 | F | 66 | Oligo-arthritis | −/−/− | — | Diffuse |
37 | F | 40 | Oligo-arthritis | −/−/− | — | Aggregate |
38 | M | 47 | Psoriatic arthritis | −/−/− | — | Diffuse |
39 | M | 39 | Sarcoidosys | −/−/− | — | Diffuse |
40 | F | 33 | Still’s disease | −/−/− | — | Aggregate |